Labshake search
Citations for R&D Systems :
1951 - 2000 of 3392 citations for Testosterone D5 98% 100 Ug Ml In Dioxane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Genomics 2023Quote: ... Neural Medium was supplemented with BDNF (20ng/ml, R&D Systems) and NT-3 (20ng/ml ...
-
bioRxiv - Cancer Biology 2023Quote: ... goat polyclonal anti-CD276 (1 µg/ml; R&D systems, #AF1027), rabbit monoclonal anti-CD3 (1:200 ...
-
bioRxiv - Bioengineering 2023Quote: ... containing 9 ng/mL Activin A (R&D systems, #338-AC), 5 ng/mL BMP4 (R&D systems ...
-
bioRxiv - Cell Biology 2023Quote: ... and 20ng/mL glial derived neurotrophic factor (GDNF, R&D Systems).
-
bioRxiv - Immunology 2023Quote: ... Fc-tagged VCAM1 (2.5 μg/ml; R&D Systems, 643-VM) and Fc-tagged DLL4 (15 μg/ml ...
-
bioRxiv - Immunology 2023Quote: ... leptin by ELISA (DY398-05, R&D Systems, LLoD 31.2pg/ml); LPS binding protein or LBP by ELISA (DY870-05 ...
-
bioRxiv - Cell Biology 2023Quote: ... and 20ng/mL brain derived neurotrophic factor (BDNF, R&D Systems). Day 9 ...
-
bioRxiv - Molecular Biology 2023Quote: ... 0.5 ng/ml human BMP4 (R&D Systems Cat# 314-BP), and 5 ng/ml human VEGF (R&D Systems Cat# ...
-
bioRxiv - Neuroscience 2023Quote: ... mouse recombinant carrier free MCSF 10 ng/mL (R&D Systems) and human recombinant TGF-β1 50 ng/mL (Miltenyi Biotec).
-
Regulation of transcription patterns, poly-ADP-ribose, and RNA-DNA hybrids by the ATM protein kinasebioRxiv - Molecular Biology 2023Quote: ... and 50 ng/ml BDNF (R&D Systems 248-BDB-250). Human RNaseH was expressed using a lentivirus derived from pTP5135 ...
-
bioRxiv - Microbiology 2023Quote: ... IFN-β (500 U/ml, R&D systems 8499-IF-010) or IFN-γ (200 U/ml ...
-
bioRxiv - Cell Biology 2023Quote: ... and 20 ng/ml FGF-2 (R&D Systems, Minneapolis, MN). Media were changed daily ...
-
bioRxiv - Biophysics 2023Quote: ... and 10 ng/mL BMP4 (R&D Systems, Cat#: 314-BP), followed by 4 more days of FGF2 and LY294002 in CDM ...
-
bioRxiv - Bioengineering 2023Quote: ... EGF (10 ng/mL, R&D Systems Cat#236-EG-01M) and N-acetylcysteine (1.5 mM ...
-
bioRxiv - Biochemistry 2023Quote: ... (v) 5 µg/ml human DC-SIGN-Fc (R&D System), 5 µg/ml human MGL-Fc (R&D System ...
-
bioRxiv - Bioengineering 2023Quote: ... and 20 ng/mL human recombinant FGF-4 (R&D Systems). After 9 to 13 days ...
-
bioRxiv - Cell Biology 2024Quote: ... supplemented with 50ng/ml Stem cell Factor (SCF, R&D Systems), 3U/ml EPO (Neocormon) ...
-
bioRxiv - Developmental Biology 2024Quote: ... BMP4 (20 -30 ng/mL, R&D systems 314-BP/CF) and WNT activator CHIR99021 (1.5 - 2.25 μmol/L ...
-
bioRxiv - Immunology 2024Quote: ... or 10 ng/mL of TNFα (210-TA, R&D systems). Wells with fresh media without any inflammatory stimuli served as control ...
-
bioRxiv - Bioengineering 2023Quote: ... with 20 ng/mL human recombinant Oncostatin M (R&D Systems). On differentiation day 25 ...
-
bioRxiv - Cancer Biology 2023Quote: ... R-Spondin 1 (R&D Systems 3474-RS; 250 ng/ml) and N-acetylcysteine (A0737 ...
-
bioRxiv - Systems Biology 2024Quote: ... 10ng/ml GDNF (R&D Systems; Cat. No. 212-GD/CF) and cultured for 2 days ...
-
bioRxiv - Systems Biology 2024Quote: ... 10ng/ml CNTF (R&D Systems; Cat. No. 257-NT/CF), 10ng/ml GDNF (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... and 20 ng/ml FGF2 (R&D Systems, #233-FB-01M). Media was changed every day from d6 – d15 ...
-
bioRxiv - Cell Biology 2024Quote: ... and 30ng/mL recombinant mouse IFNγ (R&D Systems: 485-MI).
-
bioRxiv - Neuroscience 2024Quote: ... and 10 ng/mL FGF (R&D systems; 235-F4-025) and was refreshed every three days ...
-
bioRxiv - Immunology 2024Quote: ... and anti-OPN (goat IgG) 7μg/ml (R&D Systems, France) or LAMP-1/CD107a monoclonal antibody specific for the lysosomal-associated membrane protein 1 (LAMP-1 ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant human IL-7 (5 ng/mL) (R&D Systems).
-
bioRxiv - Developmental Biology 2023Quote: ... and 200 ng/ml FGF9 (R&D Systems 273-F9-025). Media was refreshed every day ...
-
bioRxiv - Molecular Biology 2024Quote: ... and 25 ng/mL rhM-CSF (R&D Systems Minneapolis, MN). On day 13 adherent macrophages were harvested using Trypsin-EDTA (0.25% ...
-
bioRxiv - Neuroscience 2024Quote: ... supplemented with FGF2 (20 ng/ml, R&D Systems, 233-FB) and EGF (20 ng/ml ...
-
bioRxiv - Cancer Biology 2024Quote: ... and 0.18 ng/ ml CCL22 (R&D Systems, 439-MD-025) and of antibodies 5 μg/ml IgG (Diagenode ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL recombinant human EGF (R&D system; 236-EG), 0.5 µM A 83-01 (R&D Systems ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL recombinant human EGF (R&D system; 236-EG), 0.5 µM A 83-01 (R&D Systems ...
-
bioRxiv - Cancer Biology 2023Quote: ... 0.5% BSA plus 0.1/1 μg/mL CCL21 (R&D systems) was added to basolateral chambers ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/ml recombinant human VEGF 165 protein (R&D Systems), 10 ng/ml human bFGF (Invitrogen) ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/mL recombinant human VEGF 165 Protein (R&D Systems) and 0.25 ng/mL recombinant human BMP-4 Protein (R&D Systems).Cells were cultured for 28 hours ...
-
bioRxiv - Cancer Biology 2023Quote: ... or 0.2ug/mL E-selectin (Cat# 724-ES, R&D Systems) overnight at 4°C.
-
bioRxiv - Genomics 2024Quote: ... TGF-β1-induced (10 ng/mL) (R&D systems, #240-B) SSc fibroblasts were treated with 20 μM Ro5-3335 (TOCRIS ...
-
bioRxiv - Cell Biology 2020Quote: ... 100 μl plasma from each mouse was tested using the mouse CXCL1/KC duo-set (R&D Systems). The experiments were done following manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2021Quote: ... cultures were transferred to a new flask coated with 1:100 Cultrex PathClear RGF-BME (R&D Systems) for adherent expansion ...
-
bioRxiv - Neuroscience 2020Quote: ... then incubated with various concentrations (0 to 100 nM) of human recombinant tau (2N4R, R&D Systems Inc.) in the absence or presence of RAP (at a 20-fold molar excess compared to the concentration of tau ...
-
bioRxiv - Molecular Biology 2021Quote: ... Recombinant human TGFβ1 (100-B-001) and Thrombospondin-1 (3074-TH-050) were purchased from R&D Systems. Matrigel-based hydrogel culture system were employed ...
-
bioRxiv - Neuroscience 2022Quote: ... Whole blood serum samples were diluted 1:40 in 100 µL of reagent diluent (DY995; R&D Systems) and recombinant human NOTCH3 ECD (1559-NT-050 ...
-
bioRxiv - Immunology 2022Quote: ... fully differentiated monolayers were challenged with a dose curve of TNF-α (R&D Systems 210-TA-100). Anti-TNF antibody (Invivogen htnfa-mab1 ...
-
bioRxiv - Bioengineering 2023Quote: ... This was done by incubating 100 µg of recombinant human G-CSFR (381-GR/CF, R&D Systems) in 950 µL PBS for 2 h at room temperature (RT ...
-
bioRxiv - Bioengineering 2023Quote: ... The MPO content of the collected media was analyzed by ELISA (1:100 dilution, DMYE00B, R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Neuroscience 2024Quote: ... Pericytes were labeled by combining PDGFRβ (Goat anti-PDGFRβ, R&D Systems, cat. no.: AF1042, dilution: 1:100) and Mouse Aminopeptidase N/CD13 (Goat anti-CD13 ...
-
bioRxiv - Immunology 2022Quote: ... immobilized hIgG, or 50 ng/ml recombinant GM-CSF (rGM-CSF) (Bioscience, US) plus 20 ng/ml IL-4 (R&D systems Cat.No. 204-IL-010, US), for 5 days to obtain immature dendritic cells (iDC) ...
-
bioRxiv - Genomics 2023Quote: ... EpiLCs were induced in N2B27 serum-free medium without 2i and LIF and with 40 μg/mL of BSA and 10 ng/ mL bFGF (R&D Systems, Cat. No 3139-FB-025) for 72 h ...